Skip to main content

Find Clinical Trials

Home
Conditions
Graft vs Host Disease

Clinical trial condition

Graft vs Host Disease

Explore clinical trials studying Graft vs Host Disease. Study availability and eligibility vary by location and protocol.

126 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Graft vs Host Disease trial results

Completed

Impact of Adnexal Involvement of the Severity and Prognosis of Chronic Graft-versus-Host Disease

NCT01221766

Conditions: Chronic Graft vs Host Disease, Graft vs Host Disease, Immune System Diseases, +1 more
Locations: Children's Hospital Boston Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant

NCT00810602

Conditions: Graft vs Host Disease, Hematologic Diseases, Hematologic Malignancies, +5 more
Locations: University of Michigan Cancer Center Ann Arbor, Michigan, United States

Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease

NCT00136396

Conditions: Graft vs Host Disease, Immune System Diseases
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Clinical Trial With Clobetasol and Dexamethasone for Topical Treatment of Oral Lesions of Chronic Graft-versus-host Disease

NCT01699412

Conditions: Graft vs Host Disease, Immune System Diseases, Mouth Diseases, +4 more
Locations: Clementino Fraga Filho University Hospital Rio de Janeiro, Brazil

Hematology and Hemotherapy Center Campinas, São Paulo, Brazil

View Trial Details

Completed

Research Study of Visilizumab for Treatment of Acute Graft Versus Host Disease

NCT00032292

Conditions: Graft vs Host Disease, Immune System Diseases
Locations: City of Hope National Medical Center Duarte, California, United States

Stanford University Medical Center Stanford, California, United States

Washington University School of Medicine St Louis, Missouri, United States

Duke University Durham, North Carolina, United States

View Trial Details

Completed

Acute Graft-Versus-Host Disease (aGvHD) Prophylaxis With ATG-Fresenius in Matched Unrelated Donor-Stem Cell Transplantation (MUD-SCT)

NCT00655343

Conditions: Graft vs Host Disease, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: Universität Freiburg, Medizinische Klinik, Abteilung Innere Medizin I, Hämatologie/Onkologie Freiburg im Breisgau, Baden-Wurttemberg, Germany

View Trial Details

Completed

Cord Blood Serum in the Treatment of Ocular Surface Diseases

NCT01234623

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +16 more
Locations: Ophthalmology Unit, Dept.of Specialistic Surgery and Anesthesiological Sciences Bologna, Italy

View Trial Details

Completed

Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking Sirolimus

NCT00195468

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Graft vs Host Disease, +7 more
Locations: Curitiba, Paraná, Brazil

Rio de Janeiro, Brazil

Rio de Janeiro, Brazil

Porto Alegre, Rio Grande do Sul, Brazil

View all 13 locations

View Trial Details

Completed

Thymoglobuline in Non-myeloablative Allogeneic Stem-cell Transplantation

NCT00130754

Conditions: Graft vs Host Disease, Immune System Diseases, Stem Cell Transplantation
Locations: Hadassah Medical Organization Jerusalem, Israel

View Trial Details

Completed

Study Evaluating Sirolimus in Kidney Transplant Recipients

NCT00195273

Conditions: Graft vs Host Disease, Immune System Diseases, Kidney Transplantation
Locations: Oslo, Norway

Gothenburg, Sweden

Uppsala, Sweden

View Trial Details